Cargando…
Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer
OBJECTIVE(S): In the treatment of castration-resistant prostate cancer (CRPC) with bone metastases, radium-223 dichloride (Ra-223) is the only bone-targeted drug that shows survival benefits. Completing six courses of Ra-223 treatment is thought to be associated with better patient survival, but thi...
Autores principales: | Takeda, Kazuya, Kawasaki, Yoshihide, Sakayauchi, Toru, Takahashi, Chiaki, Katagiri, Yu, Tanabe, Takaya, Ishikawa, Yojiro, Fujimoto, Keisuke, Kubozono, Masaki, Kozumi, Maiko, Abe, Keiko, Narazaki, Kakutaro, Tasaka, Shun, Umezawa, Rei, Yamamoto, Takaya, Takahashi, Noriyoshi, Suzuki, Yu, Kishida, Keita, Omata, So, Ito, Akihiro, Jingu, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803628/ https://www.ncbi.nlm.nih.gov/pubmed/36619192 http://dx.doi.org/10.22038/AOJNMB.2022.67136.1468 |
Ejemplares similares
-
Palliative radiotherapy for gastric cancer bleeding: a multi-institutional retrospective study
por: Takeda, Kazuya, et al.
Publicado: (2022) -
Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study
por: Takahashi, Noriyoshi, et al.
Publicado: (2016) -
Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma
por: Takeda, Kazuya, et al.
Publicado: (2016) -
Radiation Therapy for Advanced Mucinous Carcinoma of the Breast With a Malignant Wound: A Case Report
por: Ishikawa, Yojiro, et al.
Publicado: (2022) -
Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2016)